The vaccine that protects teenage girls and young women against cervical cancer also may help prevent many oropharyngeal cancers in the United States.
A recent analysis showed that 72% of 557 invasive oropharyngeal squamous cell carcinoma samples tested positive for human papillomavirus (HPV). In nearly two-thirds of those samples, investigators detected HPV-16 and HPV-18, the strains most often linked with cervical cancer (Steinau M et al. Emerg Infect Dis. 2014;20:822-828). Previous studies had shown that HPV was present in 37% to 60% of oropharyngeal squamous cell carcinomas.
HPV Vaccine for Oropharyngeal Cancer? JAMA. 2014;312(2):122. doi:10.1001/jama.2014.7061
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: